Overview A Study of Iguratimod in Patients With Active Rheumatoid Arthritis Status: Completed Trial end date: 2015-08-01 Target enrollment: Participant gender: Summary This study is intended to evaluate the safety and efficacy of Iguratimod in patients with active Rheumatoid Arthritis. Phase: Phase 4 Details Lead Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.